{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:04:44Z","timestamp":1778177084977,"version":"3.51.4"},"reference-count":9,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Center for Advancing Translational Sciences (NCATS)","award":["UL1 TR001866"],"award-info":[{"award-number":["UL1 TR001866"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Pregnancy is a highly regulated biological condition in which a successful outcome is heavily dependent on maintaining a delicate balance through maternal\u2013fetal dialog at various levels [...]<\/jats:p>","DOI":"10.3390\/jcm13164631","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T07:01:25Z","timestamp":1723100485000},"page":"4631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Placenta-Mediated Conditions: Past, Present, and Future Perspectives"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5261-9277","authenticated-orcid":false,"given":"Amihai","family":"Rottenstreich","sequence":"first","affiliation":[{"name":"Laboratory of Blood and Vascular Biology, Rockefeller University, New York, NY 10065, USA"},{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra\/Northwell, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: Systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/uog.26222","article-title":"ASPRE trial: Effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy","volume":"61","author":"Rolnik","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rolnik, D.L., Syngelaki, A., O\u2019Gorman, N., Wright, D., Nicolaides, K.H., and Poon, L.C. (2023). Aspirin for evidence-based preeclampsia prevention trial: Effects of aspirin on maternal serum pregnan-cy-associated plasma protein A and placental growth factor trajectories in pregnancy. Am. J. Obstet. Gynecol.","DOI":"10.1016\/j.ajog.2023.12.031"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ajog.2022.10.014","article-title":"Comparative effectiveness of prophylactic strategies for preeclampsia: A network meta-analysis of randomized controlled trials","volume":"228","author":"Liu","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41586-022-04410-z","article-title":"Early prediction of preeclampsia in pregnancy with cell-free RNA","volume":"602","author":"Moufarrej","year":"2022","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101368","DOI":"10.1016\/j.ajogmf.2024.101368","article-title":"The \u201cPreeclampsia and Hypertension Target Treatment\u201d study: A multicenter prospective study to evaluate the effectiveness of the antihyper-tensive therapy based on maternal hemodynamic findings","volume":"6","author":"Giannubilo","year":"2024","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejogrb.2024.07.042","article-title":"Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo","volume":"300","author":"Ghi","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/16\/4631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:31:47Z","timestamp":1760110307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/16\/4631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":9,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jcm13164631"],"URL":"https:\/\/doi.org\/10.3390\/jcm13164631","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]}}}